Lyft price target lowered by Jefferies on US rideshare slowdown
proactiveinvestors.com
Want to monitor KYMR?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor KYMRKymera Therapeutics is a clinical-stage biopharmaceutical company focused on advancing the field of targeted protein degradation, a transformative new approach to address previously intractable disease targets.